The present invention is directed to the tosylate salt of trans-N-isobutyl- 3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-yl-methyl)-phenyl]-cyclobutanecarboxamide Formula (1): to solvates (e.g.,hydrates) thereof, to polymorphs thereof, to pharmaceuticalcompositions thereof and to a method of treating depression, mood disorders,schizophrenia, anxiety disorders, cognitive disorders,Alzheimer's disease, attention-deficit disorder (ADD), attention-deficithyperactivity disorder (ADHD), psychotic disorders, sleepdisorders, obesity, dizziness, epilepsy, motion sickness, respiratorydiseases, allergy, allergy-induced airway responses, allergicrhinitis, nasal congestion, allergic congestion, congestion, hypotension,cardiovascular disease, diseases of the G1 tract, hyper- andhypo-motility and acidic secretion of the gastro-intestinal tract comprisingadministering a therapeutically effective amount thereof.
